Wednesday, February 11, 2026
ADVT 
International

US offers more monkeypox vaccine to states and cities

Darpan News Desk The Canadian Press, 15 Aug, 2022 02:19 PM
  • US offers more monkeypox vaccine to states and cities

NEW YORK (AP) — U.S. officials said they are able to ship out more monkeypox vaccine doses than previously planned — because of a strategy shift that allows more shots to be drawn from each vial.

The U.S. Department of Health and Human Services had previously anticipated allowing 221,000 doses to be ordered starting Monday. But officials said they would release 442,000 doses for order by state, local and territorial health departments.

The accelerated release was only possible because U.S. health officials said last week that they would stretch the nation’s limited supply of Jynneos monkeypox vaccine by giving people one-fifth the usual dose, injected just under the skin. Previously, each vaccine dose required a full vial injected into deeper tissue. They cited research suggesting that the reduced amount is about as effective.

The 442,000 doses would equate to about 88,000 vials.

Officials said the new approach allows them to make hundreds of thousands more doses available now while they gather data about how the shots are being used. That will help the government make sure doses are being administered to the places and people that need them most, officials said.

U.S. officials previously shipped more than 630,000 doses, though not all have been used.

Federal health officials have suggested they would need about 3.2 million shots to vaccinate all those considered at highest risk of monkeypox.

MORE International ARTICLES

Halloween goes on at the White House with a few twists

Halloween goes on at the White House with a few twists
In years past, the president and first lady personally handed out candy to the costume-clad kids. This year, the treats were provided separately as participants walked along a path on the South Lawn.

Halloween goes on at the White House with a few twists

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic